Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Renal crystal-storing histiocytosis involving glomeruli - A comprehensive clinicopathologic analysis.

Gupta RK, Rosenberg AZ, Bagnasco SM, Arend LJ.

Ann Diagn Pathol. 2019 Aug 29;43:151403. doi: 10.1016/j.anndiagpath.2019.151403. [Epub ahead of print]

PMID:
31494491
2.

Biomarkers of Chronic Renal Tubulointerstitial Injury.

Bagnasco SM, Rosenberg AZ.

J Histochem Cytochem. 2019 Sep;67(9):633-641. doi: 10.1369/0022155419861092. Epub 2019 Jun 26.

PMID:
31242044
3.

Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates.

Delsante M, Maggiore U, Levi J, Kleiner DE, Jackson AM, Arend LJ, Hewitt SM, Carter-Monroe N, Bagnasco SM, Rosenberg AZ.

Transpl Int. 2019 Mar;32(3):300-312. doi: 10.1111/tri.13371. Epub 2018 Dec 11.

PMID:
30395360
4.

Beyond the microscope: interpreting renal biopsy findings in the era of precision medicine.

Bagnasco SM.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1652-F1655. doi: 10.1152/ajprenal.00407.2018. Epub 2018 Oct 3. Review.

5.

Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring System.

Zee J, Hodgin JB, Mariani LH, Gaut JP, Palmer MB, Bagnasco SM, Rosenberg AZ, Hewitt SM, Holzman LB, Gillespie BW, Barisoni L.

Arch Pathol Lab Med. 2018 May;142(5):613-625. doi: 10.5858/arpa.2017-0181-OA. Epub 2018 Feb 19.

6.

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.

Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A.

J Am Soc Nephrol. 2018 Feb;29(2):620-635. doi: 10.1681/ASN.2017050589. Epub 2017 Oct 17.

7.

Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.

Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM.

Nephrol Dial Transplant. 2018 Feb 1;33(2):310-318. doi: 10.1093/ndt/gfw443.

8.

Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations.

Lemley KV, Bagnasco SM, Nast CC, Barisoni L, Conway CM, Hewitt SM, Song PX.

PLoS One. 2016 Jun 10;11(6):e0157148. doi: 10.1371/journal.pone.0157148. eCollection 2016.

9.

Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection.

Orandi BJ, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, Bagnasco SM, Segev DL, Orens JB, Montgomery RA.

Am J Transplant. 2016 Oct;16(10):3041-3045. doi: 10.1111/ajt.13882. Epub 2016 Jun 27.

10.

Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.

Fahmy LM, Massie AB, Muzaale AD, Bagnasco SM, Orandi BJ, Alejo JL, Boyarsky BJ, Anjum SK, Montgomery RA, Dagher NN, Segev DL.

Transplantation. 2016 Jun;100(6):1294-8. doi: 10.1097/TP.0000000000001236.

11.

Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.

Lipson EJ, Bagnasco SM, Moore J Jr, Jang S, Patel MJ, Zachary AA, Pardoll DM, Taube JM, Drake CG.

N Engl J Med. 2016 Mar 3;374(9):896-8. doi: 10.1056/NEJMc1509268. No abstract available.

12.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

13.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

14.

Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.

Orandi BJ, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM, Zachary AA, Segev DL, Montgomery RA.

Am J Transplant. 2016 Jan;16(1):213-20. doi: 10.1111/ajt.13434. Epub 2015 Aug 28.

15.

Peritubular capillaritis in the renal allograft takes center stage.

Racusen LC, Bagnasco SM.

Kidney Int. 2015 Aug;88(2):218-20. doi: 10.1038/ki.2015.99.

16.

Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V, Eichinger F, Nair V, Gipson DS, Cattran DC, Johnstone DB, O'Toole JF, Bagnasco SM, Song PX, Barisoni L, Troost JP, Kretzler M, Sedor JR; Nephrotic Syndrome Study Network.

J Am Soc Nephrol. 2016 Mar;27(3):814-23. doi: 10.1681/ASN.2014111131. Epub 2015 Jul 6.

17.

Intimal arteritis in renal allografts: new takes on an old lesion.

Bagnasco SM, Kraus ES.

Curr Opin Organ Transplant. 2015 Jun;20(3):343-7. doi: 10.1097/MOT.0000000000000186. Review.

PMID:
25944226
18.

Quantifying renal allograft loss following early antibody-mediated rejection.

Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL.

Am J Transplant. 2015 Feb;15(2):489-98. doi: 10.1111/ajt.12982. Epub 2015 Jan 21.

19.

Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.

Sis B, Bagnasco SM, Cornell LD, Randhawa P, Haas M, Lategan B, Magil AB, Herzenberg AM, Gibson IW, Kuperman M, Sasaki K, Kraus ES; Banff Working Group.

J Am Soc Nephrol. 2015 May;26(5):1216-27. doi: 10.1681/ASN.2014020157. Epub 2014 Nov 7.

20.

Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course.

Bagnasco SM, Gottipati S, Kraus E, Alachkar N, Montgomery RA, Racusen LC, Arend LJ.

PLoS One. 2014 Oct 20;9(10):e110778. doi: 10.1371/journal.pone.0110778. eCollection 2014.

21.

Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.

Orandi BJ, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA.

Transplantation. 2014 Oct 27;98(8):857-63. doi: 10.1097/TP.0000000000000298.

PMID:
25121475
22.

Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.

Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES.

Transplantation. 2014 Feb 27;97(4):440-5. doi: 10.1097/01.TP.0000437177.40551.f4.

PMID:
24531821
23.

Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.

Sharif A, Kraus ES, Zachary AA, Lonze BE, Nazarian SM, Segev DL, Alachkar N, Arend LJ, Bagnasco SM, Racusen LC, Montgomery RA.

Transplantation. 2014 Mar 15;97(5):541-7. doi: 10.1097/01.TP.0000442513.27641.7e.

PMID:
24521779
24.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

25.

Application of systems biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation.

Pisitkun T, Gandolfo MT, Das S, Knepper MA, Bagnasco SM.

Proteomics Clin Appl. 2012 Jun;6(5-6):268-78. doi: 10.1002/prca.201100108.

26.

Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.

Alachkar N, Bagnasco SM, Montgomery RA.

Transpl Int. 2012 Aug;25(8):e93-5. doi: 10.1111/j.1432-2277.2012.01497.x. Epub 2012 May 17. No abstract available.

27.

Protein kinase C-α comes to the rescue of aquaporin-2.

Bagnasco SM.

Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F35-6. doi: 10.1152/ajprenal.00225.2012. Epub 2012 Apr 25. No abstract available.

28.

Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft.

Bagnasco SM, Subramanian AK, Desai NM.

Transpl Infect Dis. 2012 Jun;14(3):288-91. doi: 10.1111/j.1399-3062.2011.00676.x. Epub 2011 Sep 8.

PMID:
22093412
29.

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ, Crow MT, Rabb H.

Transpl Immunol. 2010 May;23(1-2):45-52. doi: 10.1016/j.trim.2010.04.002. Epub 2010 Apr 20.

30.

Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.

Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, Crow MT, King LS, Rabb H.

Kidney Int. 2009 Oct;76(7):717-29. doi: 10.1038/ki.2009.259. Epub 2009 Jul 22.

31.

Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects.

Cornish TC, Bagnasco SM, Macgregor AM, Lu J, Selvin E, Halushka MK.

J Histochem Cytochem. 2009 Nov;57(11):995-1001. doi: 10.1369/jhc.2009.954107. Epub 2009 Jun 8.

32.

Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function.

Bagnasco SM, Mohammed BS, Mani H, Gandolfo MT, Haas M, Racusen LC, Montgomery RA, Kraus E.

Nephrol Dial Transplant. 2009 Apr;24(4):1319-25. doi: 10.1093/ndt/gfn697. Epub 2008 Dec 22.

PMID:
19103737
33.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.

J Am Soc Nephrol. 2009 Jan;20(1):197-204. doi: 10.1681/ASN.2008030279. Epub 2008 Sep 5.

34.

IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features.

Haas M, Racusen LC, Bagnasco SM.

Hum Pathol. 2008 Sep;39(9):1309-16. doi: 10.1016/j.humpath.2008.02.015. Epub 2008 Jul 11.

PMID:
18619648
35.

Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Melancon JK, Tan M, Kraus ES, Rabb H, Ugarte RM, Burdick JF, Montgomery RA.

Arch Pathol Lab Med. 2008 Jan;132(1):37-42. doi: 10.1043/1543-2165(2008)132[37:AIKFHL]2.0.CO;2.

PMID:
18181671
36.

CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival.

Bagnasco SM, Tsai W, Rahman MH, Kraus ES, Barisoni L, Vega R, Racusen LC, Haas M, Mohammed BS, Zachary AA, Montgomery RA.

Am J Transplant. 2007 Aug;7(8):1968-73.

37.

The erythrocyte urea transporter UT-B.

Bagnasco SM.

J Membr Biol. 2006;212(2):133-8. Epub 2007 Jan 30. Review.

PMID:
17264984
38.

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts.

Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES.

Am J Transplant. 2007 Mar;7(3):576-85. Epub 2007 Jan 4.

39.

C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings.

Haas M, Rahman MH, Racusen LC, Kraus ES, Bagnasco SM, Segev DL, Simpkins CE, Warren DS, King KE, Zachary AA, Montgomery RA.

Am J Transplant. 2006 Aug;6(8):1829-40.

40.

Role and regulation of urea transporters.

Bagnasco SM.

Pflugers Arch. 2005 Jul;450(4):217-26. Epub 2005 May 28. Review.

PMID:
15924241
41.

Regulated expression of renal and intestinal UT-B urea transporter in response to varying urea load.

Inoue H, Kozlowski SD, Klein JD, Bailey JL, Sands JM, Bagnasco SM.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F451-8. Epub 2005 Mar 29.

42.

EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo.

Xu H, Tian W, Lindsley JN, Oyama TT, Capasso JM, Rivard CJ, Cohen HT, Bagnasco SM, Anderson S, Cohen DM.

Am J Physiol Renal Physiol. 2005 Apr;288(4):F855-66. Epub 2004 Nov 23.

43.

Identification and characterization of a Kidd antigen/UT-B urea transporter expressed in human colon.

Inoue H, Jackson SD, Vikulina T, Klein JD, Tomita K, Bagnasco SM.

Am J Physiol Cell Physiol. 2004 Jul;287(1):C30-5. Epub 2004 Feb 25.

44.

Aldosterone decreases UT-A1 urea transporter expression via the mineralocorticoid receptor.

Gertner RA, Klein JD, Bailey JL, Kim DU, Luo XH, Bagnasco SM, Sands JM.

J Am Soc Nephrol. 2004 Mar;15(3):558-65.

45.

Gene structure of urea transporters.

Bagnasco SM.

Am J Physiol Renal Physiol. 2003 Jan;284(1):F3-10. Review.

46.

Glucocorticoids inhibit transcription and expression of the UT-A urea transporter gene.

Peng T, Sands JM, Bagnasco SM.

Am J Physiol Renal Physiol. 2002 May;282(5):F853-8.

47.

Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues.

Timmer RT, Klein JD, Bagnasco SM, Doran JJ, Verlander JW, Gunn RB, Sands JM.

Am J Physiol Cell Physiol. 2001 Oct;281(4):C1318-25.

48.

Cloning and characterization of the human urea transporter UT-A1 and mapping of the human Slc14a2 gene.

Bagnasco SM, Peng T, Janech MG, Karakashian A, Sands JM.

Am J Physiol Renal Physiol. 2001 Sep;281(3):F400-6.

49.

Cloning of the rat Slc14a2 gene and genomic organization of the UT-A urea transporter.

Nakayama Y, Naruse M, Karakashian A, Peng T, Sands JM, Bagnasco SM.

Biochim Biophys Acta. 2001 Mar 19;1518(1-2):19-26.

PMID:
11267655
50.

How renal cells handle urea.

Bagnasco SM.

Cell Physiol Biochem. 2000;10(5-6):379-84. Review.

PMID:
11125219

Supplemental Content

Loading ...
Support Center